PATENT CLAIM ANALYSIS

Application Number: 16387187
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "259300"]

Abstract:
Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Claim (Index 13):
The pharmaceutical composition of  claim 12 , wherein the microparticles are prepared by spray-drying, freeze-drying or micronisation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 100.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15984747', '13099179', '12813142', '16009596', '13382145']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7811052555785162
- 35 USC 102 Novelty (BERT): 0.5633405120657277
- Combined Prediction Score: 0.7593287812272373
- Mean Citation Score: 380.54883
- Max Citation Score: 455.76596
- Similarity Product: 307.40370314920426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test